New York Law Mandates Insurance Coverage for Scalp Cooling to Prevent Chemotherapy-Induced Hair Loss
New York State Mandates Insurance Coverage for Scalp Cooling, Offering hope to Cancer Patients
New York, NY – In a landmark victory for cancer patients, New York State Governor Kathy Hochul signed legislation on December 13, 2024, requiring insurance coverage for scalp cooling systems. this groundbreaking bill (A38-A/S2063-A),championed by Assembly member Linda B. Rosenthal and State Senator Toby Ann Stavisky, aims to alleviate the emotional distress of chemotherapy-induced hair loss.
Beginning January 1,2026,private health insurance plans governed by New York law will be obligated to cover scalp cooling systems used during chemotherapy treatment. this includes innovative technologies like the Paxman Scalp Cooling System, which has gained recognition for its effectiveness in minimizing hair loss.
“This is a very encouraging development and a great way to end the year,” said Richard Paxman, CEO of Paxman. “we are seeing a lot of positive momentum around coding and coverage for scalp cooling, with the recent Palmetto LCD being implemented in November 2023 and some commercial payers beginning to reimburse scalp cooling claims. This new bill is firstly, extremely positive news for our strong customer base and patients within the New York area, but also an critically important step to ensure all applicable patients have access to scalp cooling, regardless of their financial means.”
this New York victory follows a wave of positive developments for scalp cooling accessibility. In October 2024, the American Medical Association announced three new CPT® Category I codes for mechanical scalp cooling, effective January 1, 2026. These codes pave the way for consistent reimbursement from both commercial and government payers, including Medicare and Medicaid.
Moreover, Congresswoman Rosa DeLauro introduced a federal bill (H. R.8128) in September 2024 to mandate health insurance coverage for scalp cooling devices nationwide.
The Paxman Scalp Cooling System, along with other FDA-cleared machine-based cooling systems, is currently used in over 850 cancer treatment centers across the United States, including prominent facilities in New York. Scalp cooling is also recognized as a Category 2A treatment option in the NCCN Guidelines and Compendium.
This legislation marks a significant step towards ensuring equitable access to scalp cooling, offering hope and empowerment to cancer patients facing the challenging side effects of chemotherapy.For more information about the Paxman Scalp Cooling System, visit: www.paxmanscalpcooling.com
Cooling the Blow: New York Leads the Way in Scalp Cooling Coverage for Cancer Patients
NewsDirectory3.com – In a monumental victory for cancer patients, new york State has taken a giant leap forward in addressing the emotional toll of chemotherapy. Governor Kathy Hochul signed legislation on December 13, 2024, mandating insurance coverage for scalp cooling systems, devices that substantially minimize hair loss during treatment.
this groundbreaking bill (A38-A/S2063-A), spearheaded by Assembly Member Linda B.Rosenthal and State Senator Toby Ann Stavisky, comes into effect on January 1, 2026. It compels private health insurers operating under New York law to cover these innovative technologies.
“This is a very encouraging growth,” said Richard Paxman, CEO of Paxman, a leading provider of scalp cooling systems.”We are seeing real momentum around coding and coverage for scalp cooling… This new bill is extremely positive news for our customers and patients in New York, but also a critical step to ensure that all eligible patients have access, regardless of their financial means.”
The New York victory follows a series of positive developments for scalp cooling accessibility. The American Medical Association introduced three new CPT® Category I codes for mechanical scalp cooling, effective January 1, 2026. This paves the way for consistent reimbursement from both commercial and government payers like Medicare and Medicaid. Furthermore, congresswoman Rosa DeLauro introduced a federal bill (H. R.8128) in September 2024, aiming to mandate national insurance coverage for scalp cooling devices.
The Paxman Scalp Cooling System, along with other FDA-cleared machine-based cooling systems, is currently used in over 850 cancer treatment centers across the United States, including prominent facilities in New York. Recognizing its efficacy,scalp cooling is also classified as a Category 2A treatment option in the NCCN Guidelines and Compendium.
This landmark New York legislation signifies a pivotal step towards equitable access to scalp cooling, offering hope and empowerment to cancer patients navigating the challenging side effects of chemotherapy.